News Releases

Hematologic malignancies are complex, with over 100 types, each requiring a tailored treatment approach. Despite scientific advances in blood cancer treatment, many blood disorders still lack cures or new therapies. BMS is leading innovations in hematology and cell therapy, focusing on personalized care, novel modalities, and patient-centered approaches. With over 25 programs in development, BMS is committed to advancing treatments and improving outcomes for patients, leveraging technologies like AI and fostering collaborations across the healthcare ecosystem.

Meet José, a patient who brings to life the daily challenges of living with Hypertrophic Cardiomyopathy (HCM). At Bristol Myers Squibb, we are dedicated to raising awareness and enhancing the management of this often unnoticed inherited heart condition. José's story underscores the critical importance of early diagnosis, ongoing research, and the need for improved treatments.

We invite you to listen carefully to patient experiences and unite with us to create a brighter tomorrow for all affected by this condition.

Every day, we focus on supporting people with psoriasis, one of Europe's most common skin conditions. Psoriasis is more than a skin condition; it is a chronic disease that brings daily challenges and affects both the body and the mind.

In our latest testimonial video, Ann-Sophie from Belgium shares her experiences living with psoriasis. From the daily struggles to her hopes for the medical future. Her story is one of many, but every story is unique and deserves to be heard.

From 16 to 18 September 2023, five Bristol Myers Squibb employees from Belgium and the Netherlands participated in the eighth edition of the Country 2 Country 4 Cancer (C2C4C) bike race. After months of intensive training, they will give their best during three cycling stages from Paris, across Amiens and Calais, to Dover to finish in Uxbridge (London).